HealthEquity (FRA:2HE) Tariff Resilience Score: 7/10 (As of Jul. 11, 2026)


FRA:2HE HealthEquity Inc FRA:2HE
93 GF Score
Price €81.50
GF Value €89.43
! 3 Warning Signs
View Full Analysis

What is HealthEquity Tariff Resilience Score?

HealthEquity FRA:2HE -0.61% 93 Tariff Resilience Score is 7 as of Jul. 11, 2026. GuruFocus rates FRA:2HE with a GF Score™ of 93/100 and a GF Value™ of €89.43. The stock has 3 warning signs investors should review. Among 673 Healthcare Providers & Services companies, HealthEquity ranks better than 89.15% on this metric.

HealthEquity has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

HealthEquity has HealthEquity provides health savings account services, with limited exposure to tariffs. Its operations are primarily domestic, and while it may face indirect impacts through healthcare costs, its direct vulnerability is low.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes HealthEquity might have Highly Resilient.

HealthEquity  (FRA:2HE) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

HealthEquity Tariff Resilience Score Related Terms

FRA:2HE vs HNGE, TEM, TXG: Tariff Resilience Score Comparison

For the Health Information Services subindustry, HealthEquity's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HealthEquity Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where HealthEquity's Tariff Resilience Score falls into.


FRA:2HE
93GF Score
HealthEquity Inc FRA:2HE
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 7 mean?
HealthEquity (FRA:2HE) has a Tariff Resilience Score of 7 as of Jul. 11, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, HealthEquity ranks #73 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 10.8%.
Is HealthEquity's Tariff Resilience Score too high?
HealthEquity's current Tariff Resilience Score is 7. Based on the distribution chart, HealthEquity ranks #73 out of 673 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, HealthEquity has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does HealthEquity's Tariff Resilience Score compare to HNGE and TEM?
According to the Healthcare Providers & Services industry distribution chart, HealthEquity ranks #73 out of 673 companies for Tariff Resilience Score. This places HealthEquity in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. HealthEquity's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthEquity stock overvalued right now?
HealthEquity (FRA:2HE) has a current Tariff Resilience Score of 7. The stock's GF Value™ is €89.43, compared to a current price of €81.50 — trading 8.9% below its estimated fair value. The current Tariff Resilience Score is 7. HealthEquity's overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For HealthEquity (FRA:2HE), the current Tariff Resilience Score is 7 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HealthEquity (FRA:2HE) Overvalued in 2026?

Based on GuruFocus' analysis, HealthEquity stock appears to be undervalued. The current stock price of €81.50 is trading 8.9% below its estimated GF Value™ of €89.43.

Key valuation signals for FRA:2HE:

  • Tariff Resilience Score: 7
  • GF Value™: €89.43 vs. price of €81.50 (8.9% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the FRA:2HE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HealthEquity Business Description

Other Exchanges HQY:USA
Address 15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
93GF Score

Get the complete analysis for FRA:2HE

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€81.50
Price
€89.43
GF Value